Literature DB >> 15640816

The importance of identifying a back-up donor for unrelated stem cell transplantation.

S M van Walraven1, M B A Heemskerk, J L W T Lie, R M Y Barge, J J Cornelissen, R M Egeler, L F Verdonck, N Wulffraat, M Oudshoorn.   

Abstract

The importance of identifying a back-up donor, once a primary suitable unrelated stem cell donor has been found, is often underestimated. Transplant centres erroneously count on the unrelated volunteer donors to be willing, available and medically fit for actual donation. According to our data, which includes 502 unrelated donor work-up procedures performed for 425 Dutch patients between 1987 and 2002, one of 11 work-ups ended in the primary requested donor failing to donate. Of all donor-related cancellations (N=46), 78% of the procedures were deferred due to medical reasons and 22% due to nonmedical reasons. Most of the donors deferred for medical reasons were female (P=0.005). In 50% of the cases for which a back-up donor was already identified, the patients were transplanted with a delay of less then 2 weeks; when no back-up donor was available, the median delay increased to 18 weeks. We strongly encourage implementing a search for at least one back-up donor in the primary search. Identifying a back-up donor can save precious time and complicated logistic rescheduling.

Entities:  

Mesh:

Year:  2005        PMID: 15640816     DOI: 10.1038/sj.bmt.1704812

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Authors:  Suzanna M van Walraven; Anneke Brand; Jack N A Bakker; Martin B A Heemskerk; Suzan Nillesen; Marc B Bierings; Laura B Bungener; Bouke G Hepkema; Arjan Lankester; Arnold van der Meer; Kees Sintnicolaas; Judith A E Somers; Eric Spierings; Marcel G J Tilanus; Christien E M Voorter; Jan J Cornelissen; Machteld Oudshoorn
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

Review 2.  Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

Authors:  Effie W Petersdorf
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

3.  The impact of COVID-19 on related-donor allogeneic stem cell harvest processes: A British Society of Blood and Marrow Transplantation and Cellular Therapy survey.

Authors:  Julia Wolf; Julia Lee; Rachel Pearce; Marie Wilson; John A Snowden; Kim Orchard
Journal:  Br J Haematol       Date:  2022-06-02       Impact factor: 8.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.